Dilantin

Product NDC
70518-0980
11-digit product format
705180980
Labeler code
70518
Product ID
70518-0980_dfc204b4-0649-d3ca-e053-2995a90ad220
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Phenytoin Sodium
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA084349
Marketing category
ANDA
Marketing start
2018-01-22
Marketing end
0000-00-00
Substance
PHENYTOIN SODIUM
Active strength
30 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
be8c0c29-be12-4cae-8e3b-1c71ed6b952cProduct name220250626
e3d31abf-5149-4e77-89a8-0dc73ec106f9Product name120210525
b251e19b-cfda-4a5c-8c9c-f4dad5d55ecbProduct name220200303
031bbc61-0564-1f35-2716-aa5c1d139248Product name220141218
cc830ceb-037c-a5c3-ee14-3d82c0e89e70Product name120140508
eafc3fd3-6834-3129-5bbb-8a9a495691abProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-0980-02025-11-13C16284748780-1d6a99b39-d430-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use DILANTIN ® safely and effectively. See full prescribing information for DILANTIN ® . DILANTIN ® (extended phenytoin sodium capsules), for oral use Initial U.S. Approval: 1953
70518-0980-12025-11-13C16284748780-1d6a99b39-d430-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use DILANTIN ® safely and effectively. See full prescribing information for DILANTIN ® . DILANTIN ® (extended phenytoin sodium capsules), for oral use Initial U.S. Approval: 1953
70518-0980-02024-01-30C16284748780-1d6a99b39-d430-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use DILANTIN ® safely and effectively. See full prescribing information for DILANTIN ® . DILANTIN ® (extended phenytoin sodium capsules), for oral use Initial U.S. Approval: 1953
70518-0980-12024-01-30C16284748780-1d6a99b39-d430-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use DILANTIN ® safely and effectively. See full prescribing information for DILANTIN ® . DILANTIN ® (extended phenytoin sodium capsules), for oral use Initial U.S. Approval: 1953
70518-0980-02022-06-04C16284748780-1d6a99b39-d430-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use DILANTIN ® safely and effectively. See full prescribing information for DILANTIN ® . DILANTIN ® (extended phenytoin sodium capsules), for oral use Initial U.S. Approval: 1953
70518-0980-12022-06-04C16284748780-1d6a99b39-d430-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use DILANTIN ® safely and effectively. See full prescribing information for DILANTIN ® . DILANTIN ® (extended phenytoin sodium capsules), for oral use Initial U.S. Approval: 1953
70518-0980-02022-01-28C16284748780-1d6a99b39-d430-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use DILANTIN ® safely and effectively. See full prescribing information for DILANTIN ® . DILANTIN ® (extended phenytoin sodium capsules), for oral use Initial U.S. Approval: 1953
70518-0980-12022-01-28C16284748780-1d6a99b39-d430-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use DILANTIN ® safely and effectively. See full prescribing information for DILANTIN ® . DILANTIN ® (extended phenytoin sodium capsules), for oral use Initial U.S. Approval: 1953

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-0980DILANTIN (PHENYTOIN SODIUM) CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC.]5Legacy NDC20220604_f1d41925-3be0-42a8-86f8-181569399c5b.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-0980-07051809800030 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (70518-0980-0) 2018-01-220000-00-00NoNoCurrent
70518-0980-170518098001100 POUCH in 1 BOX (70518-0980-1) > 1 CAPSULE, EXTENDED RELEASE in 1 POUCH (70518-0980-2) 100 pouch2020-01-060000-00-00NoNoCurrent